Carrageenan structure
|
Common Name | Carrageenan | ||
---|---|---|---|---|
CAS Number | 11114-20-8 | Molecular Weight | 788.65800 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C24H36O25S2-- | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A |
Use of Carrageenanκ-Carrageenan is a natural polymer which predominantly available in red seaweeds. κ-Carrageenan is an effective drug carrier to deliver curcumin in cancer cells and to induce apoptosis. κ-carrageenan serves as a potential inflammatory agent that magnifies existing intestinal inflammation[1][2]. |
Name | κ-carrageenan |
---|
Description | κ-Carrageenan is a natural polymer which predominantly available in red seaweeds. κ-Carrageenan is an effective drug carrier to deliver curcumin in cancer cells and to induce apoptosis. κ-carrageenan serves as a potential inflammatory agent that magnifies existing intestinal inflammation[1][2]. |
---|---|
Related Catalog | |
In Vitro | κ-Car- Curcumin (Cur) (0-500 μg/mL; 24-72 hours) effectively involves in cancer cell growth inhibition at lower concentrations of 40 µg/mL[1]. The cytotoxicity of the Cur loaded κ-Car has a significantly high apoptotic activity in selected lung cancer cells of A549[1]. κ-Carrageenan (1-60 μg/mL; 0.5-24 hours) enhances LPS-induced IL-8 secretion in HT-29 cells[2]. Cell Viability Assay[1] Cell Line: A549 cells Concentration: 0-500 μg/mL Incubation Time: 24, 48 and 72 hours Result: The dose response effects of cells treated with Cur loaded κ-Car after incubation of 24, 48 and 72 h exhibited a significant IC50 values of 65, 50 and 40 μg/mL respectively, for 24, 48, 72 h ours. |
In Vivo | κ-Carrageenan (1.7-41.7 mg/kg; p.o. for 1 week prior to C. freundii DBS100 treatment) can synergistically activate LPS-induced inflammatory through the Bcl10-NF-κB pathway, as indicated by its aggravation of C. freundii DBS100-induced colitis in mice[2]. κ-Carrageenan enhances the C. freundii DBS100-dependent induction of TLR4 and NF-κB in the intestinal mucosa of infected mice[2]. κ-Carrageenan aggravated the TNBS-induced intestinal inflammation, and such an effect could be associated with the oxidative stress and activation of TLR4-NF-κB and MAPK/ERK1/2 pathway[3] Animal Model: Male and female NIH (s) mice[2] Dosage: 1.7 mg/kg, LOW; 8.3 mg/kg, MED; or 41.7 mg/kg, HIG Administration: Orally administered for 1 week prior to C. freundii DBS100 treatment Result: Enhanced the C. freundii DBS100-dependent induction of TLR4 and NF-κB in the intestinal mucosa of infected mice. |
References |
Molecular Formula | C24H36O25S2-- |
---|---|
Molecular Weight | 788.65800 |
Exact Mass | 788.09900 |
PSA | 394.53000 |
Appearance of Characters | Solid | White to almost white to yellow to brownish |
Water Solubility | H2O: 5 mg/mL hot, soluble |
Hazard Codes | F+ |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 2 |
RTECS | FI0704000 |
Layer-by-layer assembled cell instructive nanocoatings containing platelet lysate.
Biomaterials 48 , 56-65, (2015) Great efforts have been made to introduce growth factors (GFs) onto 2D/3D constructs in order to control cell behavior. Platelet lysate (PL) presents itself as a cost-effective source of multiple GFs ... |
|
Self-assembled carrageenan/protamine polyelectrolyte nanoplexes-Investigation of critical parameters governing their formation and characteristics.
Carbohydr. Polym. 123 , 339-49, (2015) The aim of this work was to investigate the feasibility of cross-linker free polyelectrolyte complex formation at the nanoscale between carrageenan (CAR) and protamine (PROT). The properties of CAR/PR... |
|
Immobilization of cells in carrageenan.
Meth. Enzymol. 135 , 189, (1987)
|